2026-10-27 11:01:01 UTC#520631newforecastnews
SOPH stock news
SOPH stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire16 wire items
2026-10-12 11:27:56 UTC#446197newconfirmednews
HC Wainwright reiterates Buy rating on Sophia Genetics, maintains $14 price target
2026-10-08 14:48:44 UTC#433248updateconfirmednews
AstraZeneca Joins Myriad Genetics and SOPHiA GENETICS in Prostate Cancer Diagnostic Partnership
seeking alphaimportance 0.50trust 0.70Myriad Genetics, Inc. +0.40SOPHiA GENETICS SA +0.40AstraZeneca PLC +0.50
2026-10-08 13:00:00 UTC#432602newconfirmedpress release
SOPHiA GENETICS and Myriad Genetics Partner to Advance Prostate Genomic Instability Score Technology
2026-10-08 13:00:00 UTC#432597newconfirmedpress release
Myriad Genetics and SOPHiA GENETICS Partner to Advance Prostate Cancer Genomic Instability Score Technology
yahooimportance 0.40trust 0.90Myriad Genetics, Inc. +0.40SOPHiA GENETICS SA +0.40AstraZeneca PLC +0.40+2 entities
2026-10-08 13:00:00 UTC#432596newconfirmedpress release
SOPHiA GENETICS and Myriad Genetics Partner to Advance PrGIS Prostate Cancer Diagnostic Technology
yahooimportance 0.40trust 0.90SOPHiA GENETICS SA +0.40Myriad Genetics, Inc. +0.40AstraZeneca PLC +0.30+2 entities
2026-08-04 13:32:38 UTC#123395duplicateconfirmednews
Sophia Genetics SA Q2 2026 Adjusted Loss $0.28/Share vs $0.21/Share Expected, Revenue $23.31M Beats Estimates
2026-08-04 11:45:26 UTC#122655duplicateconfirmednews
SOPHiA GENETICS Q2 2026 Revenue $23.3M, Raises FY26 Guidance to $94M-$96M
2026-08-04 11:05:58 UTC#122461duplicateconfirmednews
SOPHiA GENETICS Q2 revenue grows 27% on liquid biopsy demand, raises 2026 revenue guidance to $94M-$96M
2026-08-04 10:46:00 UTC#122255updateconfirmednews
SOPHiA GENETICS (SOPH) projects 2026 revenue of $94M-$96M
2026-08-04 10:45:00 UTC#122331duplicateconfirmedpress release
SOPHiA GENETICS Reports Q2 2026 Revenue of $23.3M, Raises Full-Year Revenue Guidance to $94M-$96M
2026-08-04 10:45:00 UTC#122330duplicateconfirmednews
SOPHiA GENETICS reports Q2 2026 revenue of $23.3 million
2026-08-04 10:45:00 UTC#122326updateconfirmeddata release
SOPHiA GENETICS reports Q2 2026 loss of $0.30 per share
2026-08-03 11:01:12 UTC#116130newforecastnews
SOPHiA GENETICS (SOPH) Q2 2026 Earnings Preview: Analysts Forecast $21.72M Revenue and ($0.21) EPS
2026-07-28 11:01:23 UTC#87091newconfirmednews
SOPHiA GENETICS (SOPH) Q2 2026 Earnings Preview: $21.72M Revenue and ($0.21) EPS Expected
2026-07-20 10:30:00 UTC#51741newconfirmednews